glp 1 for inflammatory arthritis GLP-1 Medications and Rheumatoid Arthritis: What a New Study Shows How Could GLP-1 Agonists Help

Ongoing Phase 3 Trials Several phase 3 trials are underway investigating the efficacy of retatrutide in larger populations (Fig

10.1016/j.cbd.2016.01.004 46 KruegerM

doi: 10.3389/fnagi.2025.1601602 Received 28 March 2025 Accepted 03 July 2025 Published 24 July 2025 Volume 17 - 2025 Edited by Rita Machado De Olivera, New University of Lisbon, Portugal Reviewed by Venkateswarlu Kanamarlapudi, Swansea University Medical School, United Kingdom Joon W Shim, Marshall University, United States Updates Copyright 2025 Li, Huang, Wang, Huang, Shi, Luo and Huang

More than 40 active competitors are developing or distributing GLP-1 receptor agonist therapies, including Ozempics original manufacturers and stepped-up biosimilar entrants

it asks the patient to rate their sexual function now compared to before (ranging from very much improved to very much worse)